Insulin Syringes Market to Reach $2.40 Bn, Globally, by 2030 at 4.4% CAGR: Allied Market Research

·5 min read

Increase in prevalence of diabetes, surge in the geriatric population, and rise in healthcare expenditure have boosted the growth of the global insulin syringes market.

PORTLAND, Ore., Jan. 20, 2022 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Insulin Syringes Market by Syringe Size (3/10 cc Syringe (0.3ml), 1/ 2 cc Syringe (0.5ml), 1cc syringe (1ml), and Others), Disease (Type-1 Diabetes and Type-2 Diabetes), End User (Hospital & Clinics, Homecare Settings, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030". As per the report, the global insulin syringes industry was pegged at $1.56 billion in 2020, and is expected to reach $2.40 billion by 2030, growing at a CAGR of 4.4% from 2021 to 2030.

Allied_Market_Research_Logo
Allied_Market_Research_Logo

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/3740

Major determinants of the market growth

Increase in prevalence of diabetes, surge in the geriatric population, and rise in healthcare expenditure have boosted the growth of the global insulin syringes market. However, high price of insulin and the availability of alternative modes of insulin delivery hinder the market growth. On the contrary, high growth potential in developing countries is expected to open new opportunities for the market players in the future.

Covid-19 scenario:

  • The Covid-19 pandemic led to a lockdown and imposed social distancing measures across several countries. The lockdown disrupted the supply chain, production, and distribution.

  • Patients with high blood pressure and diabetes are at higher risk of getting affected by the virus. Thus, the demand for insulin administration surged during the pandemic.

The type-2 diabetes segment to manifest the highest CAGR through 2030

By disease, the type-2 diabetes segment is estimated to portray the highest CAGR of 4.9% during the forecast period. In addition, the segment held the largest share in 2020, accounting for nearly three-fifths of the market, owing to rise in case of type 2 diabetes across the world. The research also analyzes the type-1 diabetes segment.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/3740

The clinics segment dominated the market

By end user, the hospital & clinics segment held the largest share in 2020, contributing to nearly half of the market. In addition, the segment is projected to manifest the highest CAGR of 5.3% during the forecast period, owing to rise in prevalence of chronic diseases such as diabetes and increase in elderly population. The report also analyzes the segments including homecare and others.

North America held the lion's share

By region, the market across North America held the largest share in 2020, accounting for nearly two-fifths of the market. This is due to high expenditure on R&D, well-established healthcare infrastructure, and presence of major players & their product availability. However, the market across Asia-Pacific is expected to register the highest CAGR of 6.5% during the forecast period, owing to improvement in R&D facilities, rapidly developing economic conditions, and disposable income.

Major market players

  • Novo Nordisk A/S

  • Abbott Laboratories

  • Biocon Ltd.

  • Cardinal Health Inc.

  • Terumo Corporation

  • Eli Lilly and Company

  • Beckton and Dickinson Company

  • Nipro Medical Corporation

  • Medline Industries

  • Hindustan syringe and medical device Ltd.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Medical Laser Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Minimally Invasive Surgical Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Enteric Softgel Capsules Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Cell Culture Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Disposable Syringes Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Surrogacy Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Infection Control Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Hospital-Acquired Infection Control Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Surgical Robotics Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Cryotherapy Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/insulin-syringes-market-to-reach-2-40-bn-globally-by-2030-at-4-4-cagr-allied-market-research-301464864.html

SOURCE Allied Market Research